The Ultimate Guide to Exemestane

Exemestane was first approved by the FDA in 1995 and is manufactured by Sanofi-Aventis under the brand name Aromasin. It’s typically used to treat breast cancer after other treatments have failed in women who are in their early postmenopausal years. What Is Exemestane? Exemestane is a potent synthetic estrogen and progesterone receptor antagonist which is …

The Ultimate Guide to Exemestane Read More »